Published in Int J Mol Cell Med on January 01, 2012
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell (2009) 11.65
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med (2006) 7.28
Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation (2004) 6.43
Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res (2004) 6.34
Tissue engineering of a differentiated cardiac muscle construct. Circ Res (2002) 4.50
Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol (2009) 4.32
Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells (2004) 4.31
Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res (2002) 3.69
Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg (2002) 3.62
Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res (2002) 3.52
Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem (2003) 3.41
Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet (2003) 3.40
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Potential risks of bone marrow cell transplantation into infarcted hearts. Blood (2007) 2.97
Matrix cells from Wharton's jelly form neurons and glia. Stem Cells (2003) 2.95
Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells (2005) 2.74
Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation (1999) 2.68
Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells (2003) 2.53
Aging of mesenchymal stem cells. Ageing Res Rev (2005) 2.53
Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev (1993) 2.48
Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol (2006) 2.48
Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells (2007) 2.46
Small-diameter artificial arteries engineered in vitro. Circ Res (2006) 2.40
Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells (2008) 2.19
TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro. Stem Cell Res (2008) 1.98
Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng (2000) 1.96
Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev (2001) 1.94
Biomaterials for stem cell differentiation. Adv Drug Deliv Rev (2007) 1.83
Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) (2004) 1.82
Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement. FASEB J (2000) 1.74
Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells (2008) 1.68
Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant (2003) 1.66
Stem cells in the umbilical cord. Stem Cell Rev (2006) 1.63
Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg (2007) 1.57
The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng (2002) 1.56
Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater (2005) 1.56
The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology (2008) 1.46
Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation (2002) 1.45
Tissue engineering: current state and prospects. Annu Rev Med (2001) 1.42
Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A (2002) 1.36
Engineering organs. Curr Opin Biotechnol (2009) 1.35
A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials. Biomaterials (2003) 1.34
Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res (2006) 1.32
Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev (2011) 1.30
Strategies for directing the differentiation of stem cells into the cardiomyogenic lineage in vitro. Cardiovasc Res (2004) 1.29
Stem cell plasticity. Blood Rev (2005) 1.29
Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol (2008) 1.25
Myocardial tissue engineering: a review. J Tissue Eng Regen Med (2007) 1.24
5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang (2008) 1.23
Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells (2005) 1.19
Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol Int (2008) 1.18
Myocardial tissue engineering. Br Med Bull (2008) 1.17
In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg (2007) 1.14
Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs (2001) 1.14
Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells. Tissue Eng (1999) 1.14
Assessment of stem cell/biomaterial combinations for stem cell-based tissue engineering. Biomaterials (2007) 1.12
Cardiac tissue engineering for replacement therapy. Heart Fail Rev (2003) 1.09
Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng (2003) 1.07
Microgravity tissue engineering. In Vitro Cell Dev Biol Anim (1997) 1.05
Bioreactors for tissue engineering. Biotechnol Lett (2006) 1.05
Adult stem cell therapy for the heart. Int J Biochem Cell Biol (2004) 1.05
Reproducible methodology for the isolation of mesenchymal stem cells from human umbilical cord and its potential for cardiomyocyte generation. J Tissue Eng Regen Med (2008) 1.04
Cell transplantation for myocardial repair: an experimental approach. Cell Transplant (1992) 1.03
Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artif Organs (2002) 1.03
Morphology, proliferation, and osteogenic differentiation of mesenchymal stem cells cultured on titanium, tantalum, and chromium surfaces. J Biomed Mater Res A (2008) 1.02
Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. J Immunol Methods (2010) 1.02
Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol Prog (2009) 1.02
A three-dimensional scaffold with precise micro-architecture and surface micro-textures. Biomaterials (2009) 1.01
Tissue engineering of recellularized small-diameter vascular grafts. Tissue Eng (2005) 1.01
In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun (2005) 1.01
Cell therapy for modification of the myocardial electrophysiological substrate. Circulation (2008) 0.99
An introduction to stem cells. J Pathol (2002) 0.99
Bioengineered tissues: the science, the technology, and the industry. Orthod Craniofac Res (2005) 0.99
Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng (2007) 0.99
A lightweight polypropylene mesh (TiMesh) for laparoscopic intraperitoneal repair of abdominal wall hernias: comparison of biocompatibility with the DualMesh in an experimental study using the porcine model. Surg Endosc (2006) 0.99
Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review. Tissue Eng (2006) 0.96
Stromal differentiation and architecture of the human umbilical cord. Placenta (1997) 0.95
Attachment, morphology and adherence of human endothelial cells to vascular prosthesis materials under the action of shear stress. Biomaterials (2005) 0.94
A biomimetic hierarchical scaffold: natural growth of nanotitanates on three-dimensional microporous Ti-based metals. Nano Lett (2008) 0.91
Cell therapy in myocardial infarction. Cardiovasc Revasc Med (2007) 0.90
Tissue engineering of vascular bypass grafts: role of endothelial cell extraction. Eur J Vasc Endovasc Surg (2001) 0.90
Electrostatic endothelial cell seeding technique for small-diameter (<6 mm) vascular prostheses: feasibility testing. Cell Transplant (1998) 0.89
Heart regeneration: what cells to use and how? Curr Opin Pharmacol (2008) 0.89
Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Fail Rev (2003) 0.89
Cardiac potential of stem cells from whole human umbilical cord tissue. J Cell Biochem (2009) 0.89
Cardiovascular tissue engineering: state of the art. Pathol Biol (Paris) (2005) 0.86
Grooves affect primary bone marrow but not osteoblastic MC3T3-E1 cell cultures. Biomaterials (2001) 0.85
Scaffolds and biomaterials for tissue engineering: a review of clinical applications. Clin Otolaryngol Allied Sci (2003) 0.85
New pulsatile bioreactor for fabrication of tissue-engineered patches. J Biomed Mater Res (2001) 0.84
Functional tissue engineering requires bioreactor strategies. Tissue Eng Part A (2009) 0.84
Cardiac differentiation of P19CL6 cells by oxytocin. Int J Cardiol (2008) 0.83
Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo. J Vasc Surg (2003) 0.83
Cell therapy for heart disease: great expectations, as yet unmet. Heart Lung Circ (2008) 0.82
Myocardial regeneration strategies using human embryonic stem cell-derived cardiomyocytes. J Control Release (2006) 0.81
Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair. Stem Cell Rev (2010) 0.81
Comparative analysis of adherence, viability, proliferation and morphology of umbilical cord tissue-derived mesenchymal stem cells seeded on different titanium-coated expanded polytetrafluoroethylene scaffolds. Biomed Mater (2010) 0.80